The Legal 500 Asia Pacific 2024 Recognizes Cooley

Beijing and Shanghai – November 22, 2023 – The Legal 500 Asia Pacific has recognized Cooley practices across China, highlighting the firm’s investment funds, life sciences and healthcare, and private equity teams as top practice groups.

Partner Christina Zhang was recommended as a Leading Individual, while partner Jingyi Xu was highlighted as a Next Generation Partner. In addition, partner Ruomu Li was recognized as a Leading Individual and a Next Generation Partner in several practice areas.

The following Cooley practices and lawyers were ranked in The Legal 500 Asia Pacific 2024 guide:

Leading Practice Groups – China
Investment Funds: Foreign Firms 
Life Sciences and Healthcare: Foreign Firms
Private Equity: Foreign Firms

Leading Individuals
Ruomu Li – Corporate and M&A, China
Christina Zhang – Life Sciences and Healthcare, China

Next Generation Partner
Ruomu Li – Life Sciences and Healthcare, China; Private Equity, China
Jingyi Xu – Investment Funds, China

Key Lawyers – Investment Funds: Foreign Firms
Pang Lee, China
Jordan Silber, China
Xun Zeng, China

Key Lawyers – Life Sciences and Healthcare: Foreign Firms – China
Ruomu Li
Yiming Liu
Patrick Loofbourrow
Christina Zhang

Key Lawyers – Private Equity: Foreign Firms – China
Ruomu Li
Yiming Liu
Patrick Loofbourrow
Christina Zhang
Lunga Su

Cooley represents a growing number of Asia’s most innovative and dynamic tech and life sciences companies, advising at all stages of the business life cycle, from formation through financings and exits. Among all international law firms practicing in Asia, Cooley has one of the largest offshore fund formation teams resident in mainland China, offering the deepest experience and greatest reach and depth for China venture capital fund formation – especially for VC firms focused on early and growth stages.

In addition, Cooley’s Asia team has in-depth subject matter knowledge and transactional prowess, enabling the firm to handle a raft of corporate, finance, licensing, M&A, and capital markets work for international and Asia-based life sciences and technology entities engaged in inbound and outbound services. The team’s in-depth subject matter knowledge and transactional prowess enable the firm to handle a raft of corporate, finance, licensing, M&A, and capital markets work for international and Asia-based life sciences and technology entities engaged in inbound and outbound services.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.